Back to blog
|Nelson Marques, MS, RD, LD

Iron-Status Workup in Female Athletes: The Ferritin → Transferrin Saturation → Reticulocyte Hemoglobin Protocol

Most labs flag iron deficiency only at the rickets-era hemoglobin threshold. By then the athlete has been performance-decremented for months. The fix is a three-marker primary panel — ferritin + transferrin saturation + reticulocyte hemoglobin — read against hs-CRP and the contraceptive method, with an every-other-day supplementation protocol that absorbs better than daily dosing.

ClinicalFemale AthleteIronBloodworkRD Practice

Order a comprehensive metabolic panel + iron studies on a female athlete and watch what the lab reports back. Serum iron 60-150 mcg/dL. TIBC 250-400 mcg/dL. A transferrin saturation calculated from those two. Ferritin between 15 and 200 ng/mL with an asterisk noting "below 15 = deficiency." Hemoglobin between 12 and 16. The lab interpretation: "Iron studies within reference range."

The female athlete is in pre-anemic iron depletion. Her training is plateauing. Her recovery is stretching out. Her conditioning ceiling has dropped 5-10%. The labs say she's fine. The athlete in front of you is not.

This gap — between the lab reference range and the athlete-appropriate target — is the most common source of missed iron-status calls in sports nutrition practice. The reference range is a rickets-era number designed to catch overt anemia in sedentary populations. Sports populations need a tighter cutoff, a multi-marker interpretation, and a protocol that gets to the diagnosis before the hemoglobin drops.

This post is the iron-status workup I run on every female-athlete intake. The three-marker primary panel, the reflex add-ons when the primary panel is ambiguous, the interpretation matrix that combines them, the contraceptive method × iron status table, the supplementation protocol once depletion is confirmed, and the referral threshold for going outside RD scope.

Why iron deserves its own workup

Three reasons female athletes warrant a dedicated iron-status workup, not a footnote in the menstrual chart:

Iron deficiency without anemia is the dominant clinical phenotype. The classical presentation — pale conjunctiva, fatigue, pica, microcytic anemia — is the late stage. Stage 1 is iron depletion: serum ferritin drops while hemoglobin holds. Stage 2 is iron-deficient erythropoiesis: ferritin is depleted, transferrin saturation drops, but hemoglobin is still in range. Stage 3 is iron-deficiency anemia: hemoglobin finally drops, MCV drops, the lab flags the case. Stages 1 and 2 are where most female athletes live. They are not flagged by a CBC + ferritin alone.

Athletic iron losses outpace sedentary baselines. Foot-strike hemolysis during running and impact-sport training, GI micro-bleeding during heavy training, sweat losses (~0.4 mg iron per liter of sweat), and hepcidin suppression of absorption in the 6-24 hours post-exercise all combine to make athletic iron requirements 30-70% higher than the sedentary RDA. The 18 mg/day adult female RDA was written for a population that doesn't train. A female endurance athlete in a heavy block can need 30-50 mg/day to maintain balance.

Menstrual and contraceptive cross-references matter. A female athlete on a copper IUD is losing 20-50% more iron per cycle than baseline (see [menstrual cycle charting in the female athlete intake](/blog/menstrual-cycle-charting-in-female-athlete-intake) for the contraceptive method × iron status detail). A female athlete on a combined hormonal contraceptive has reduced menstrual blood loss and lower iron requirements. The two athletes need different supplementation protocols and different monitoring cadence — and the intake form has to surface that distinction before the iron workup starts.

Documenting iron status as a standalone clinical workup, distinct from the CBC the PCP ordered six months ago, is the structural fix.

The three-marker primary panel

Order: ferritin + transferrin saturation + reticulocyte hemoglobin equivalent (Ret-He or CHr).

These three markers, read together, capture the stage of iron status the athlete is in regardless of where she falls in the depletion progression.

Ferritin is the storage marker. Serum ferritin reflects the body's iron reserves; low ferritin means depleted stores. Athlete-appropriate target: ≥40 ng/mL for general training, ≥50 ng/mL during heavy training blocks, ≥60 ng/mL for endurance athletes preparing for a key event. The lab's "≥15 ng/mL" threshold catches overt deficiency but misses the depletion window where performance starts to suffer.

Ferritin's complication: it is an acute-phase reactant. Inflammation from a recent illness, heavy training block, or surgery can elevate ferritin and mask depleted stores. Always read ferritin alongside hs-CRP (high-sensitivity C-reactive protein). If hs-CRP is elevated (>3 mg/L), ferritin is unreliable as a deficiency marker — discount it and lean on transferrin saturation and Ret-He.

Transferrin saturation (TSAT) is the transport marker. TSAT reflects how much of the iron-transport protein transferrin is currently carrying iron. Athlete-appropriate target: ≥25%. Below 20% indicates functional iron deficiency even if ferritin reads acceptable. TSAT is not an acute-phase reactant — it is reliable in the presence of inflammation.

The combination of normal ferritin + low TSAT is the classical signature of inflammation-masked iron deficiency. The athlete needs iron despite the ferritin reading.

Reticulocyte hemoglobin equivalent (Ret-He or CHr) is the production marker. Ret-He reflects how much iron is being incorporated into newly produced red blood cells over the last 1-3 days. It is the most temporally sensitive marker of iron status — it changes within 48-72 hours of intervention, while ferritin and hemoglobin take weeks.

Ret-He target: ≥29 pg. Below 28 pg indicates that erythropoiesis is iron-restricted right now, regardless of what ferritin and TSAT look like. Ret-He is not on every standard panel — order it specifically. Most major labs (Quest, LabCorp, Mayo) offer it on the CBC-with-reticulocyte order, often labeled "RET-HE" or "MCH-r."

The interpretation matrix

The three markers combined produce a four-quadrant interpretation:

1. All three in range (ferritin ≥40, TSAT ≥25%, Ret-He ≥29). Iron status is adequate for current training. Recheck in 6 months or after a meaningful training-block change.

2. Ferritin low, TSAT and Ret-He in range. Stage 1 iron depletion. Stores are dropping but erythropoiesis hasn't compromised yet. Begin supplementation now to prevent stage 2 progression. Recheck ferritin in 8 weeks.

3. Ferritin low + TSAT low, Ret-He still in range. Stage 2 iron-deficient erythropoiesis. The athlete is actively iron-limited but the lab won't flag her until hemoglobin drops. Performance decrement is already happening even though she's "not anemic." Aggressive supplementation; recheck all three markers + hemoglobin in 6 weeks.

4. All three abnormal + hemoglobin dropping. Stage 3 iron-deficiency anemia. Supplementation alone may not be enough. Refer to PCP for GI workup (occult blood, H. pylori screen, celiac if not previously ruled out) before assuming the deficiency is purely dietary. The [low energy availability screening](/blog/screening-athletes-for-low-energy-availability) should also be run — chronic LEA suppresses hepcidin and impairs iron absorption, and the iron deficiency may be downstream of the energy-availability problem.

The ambiguous case: normal ferritin, low TSAT, normal or low Ret-He. Inflammation may be masking depletion (check hs-CRP), or the athlete may be in a recovery-from-supplementation phase where stores are rebuilding while transport is still tight. Repeat in 4 weeks; if the pattern persists, treat as functional deficiency.

The contraceptive method × iron status table

Pulling forward the cross-reference from the [menstrual cycle charting](/blog/menstrual-cycle-charting-in-female-athlete-intake) post — the contraceptive method changes the iron monitoring cadence and the supplementation prescription:

Copper IUD. Increases menstrual blood loss 20-50%. Iron-deficiency anemia risk meaningfully elevated. Baseline iron studies at intake; recheck every 6 months; aggressive supplementation if any marker drops; consider 30-50 mg/day elemental iron continuously during heavy training blocks.

Hormonal IUD (Mirena, Kyleena, Liletta, Skyla). Typically reduces flow and improves iron status. Baseline at intake; recheck annually unless symptoms emerge.

Combined oral contraceptive, patch, ring. Lighter withdrawal bleed than natural cycle. Iron status usually preserved. Baseline at intake; recheck annually.

Progestin-only pill, Depo-Provera, implant. Variable bleed pattern. Baseline at intake; recheck cycle bleed pattern at 6 months and adjust monitoring cadence accordingly.

No contraception, regular cycle. Standard menstrual losses (~30-40 mL per cycle averaged across the year). Baseline at intake; recheck annually or after any training-block change.

No contraception, irregular cycle or amenorrhea. Iron status may be deceptively preserved (no menstrual loss = no iron leak) but the underlying cause is RED-S until proven otherwise. The [low energy availability screening](/blog/screening-athletes-for-low-energy-availability) is the primary workup; iron studies are secondary.

The supplementation protocol

Once depletion is confirmed, the supplementation protocol turns on three decisions: dose, form, and timing.

Dose. Begin at 30-65 mg elemental iron per day. Lower end (30 mg) for stage 1 depletion; higher end (60-65 mg) for stage 2-3 deficiency or for an athlete on a copper IUD in a heavy training block.

The dose-response curve plateaus around 80-100 mg/day. Above that, GI side effects (constipation, nausea, dark stool) climb sharply without additional absorption benefit. Splitting the dose across the day does not improve absorption — recent research (Stoffel et al. 2017, Moretti 2015) suggests every-other-day single-dose supplementation absorbs better than daily split dosing because hepcidin elevation from yesterday's dose suppresses today's absorption.

The default protocol: 60 mg elemental iron, every other day, with vitamin C 250-500 mg in the same dose, taken on an empty stomach 60 minutes before food. The every-other-day schedule maintains hepcidin suppression and recovers absorption efficiency; vitamin C reduces ferric to ferrous iron and improves uptake.

Form. Iron bisglycinate (chelated iron) and iron sulfate are the two practical choices. Bisglycinate has cleaner GI tolerability at the cost of higher per-tablet price. Sulfate is cheaper but causes more GI symptoms; some athletes simply can't tolerate it. Heme iron polypeptide is a third option for severely intolerant patients; it absorbs cleanly but costs 3-5x bisglycinate. Avoid iron gluconate at high doses (lower elemental percentage per pill) and ferric forms (poorly absorbed).

Timing. On an empty stomach is the absorption-optimal recommendation but often intolerable for athletes with sensitive stomachs. The fallback: take iron with a small portion of acidic food (orange juice, kiwifruit, a single piece of fruit) and away from any of the following major absorption blockers: dairy/calcium, coffee, tea, eggs, whole-grain breads/cereals, calcium supplements, magnesium supplements, zinc supplements.

The supplement reconciliation matters here. An athlete on a calcium-containing multivitamin or a ZMA stack is blocking the iron absorption she's also paying for. The [supplement reconciliation](/blog/supplement-reconciliation-in-sports-nutrition-intake) workup catches the stack interactions.

When to refer out

Three patterns push the case outside RD scope and into the PCP / hematology / GI referral pathway:

1. Hemoglobin <11 g/dL or rapidly dropping. Refer for GI workup (occult blood, H. pylori, celiac) before assuming dietary cause. Continue supplementation in parallel but don't be the only provider on the case.

2. Iron deficiency that doesn't respond to 8-12 weeks of correct supplementation. Either absorption is impaired (celiac, atrophic gastritis, H. pylori, PPI use), ongoing loss is exceeding the supplementation rate (GI bleed, very heavy menstrual bleeding), or the athlete is not actually taking the supplement as prescribed. The first two require workup the RD can't run; the third requires a different conversation.

3. Ferritin >300 ng/mL in an athlete not currently supplementing aggressively. Possible hereditary hemochromatosis or chronic inflammatory state. Refer for HFE genotyping and inflammation workup before continuing.

Where this lands in the SOAP

Objective section format:

```

Iron Status (drawn YYYY-MM-DD):

  • Ferritin: [value] ng/mL (target ≥40, or ≥50 in heavy training)
  • TSAT: [value]% (target ≥25%)
  • Ret-He: [value] pg (target ≥29)
  • hs-CRP: [value] mg/L (read ferritin context)
  • Hemoglobin: [value] g/dL
  • Stage: [adequate / depletion / functional deficiency / anemia]
  • Contraceptive context: [method, cycle pattern]

```

Assessment integrates the stage classification with the menstrual context, the training load, and the energy-availability picture. Plan documents the supplementation protocol, the next-recheck date, and any referrals being initiated. The [body composition reports](/blog/body-composition-reports-as-bayesian-priors) workup pairs with this — iron-deficient athletes show altered body-composition trajectories that the BIA reading alone won't explain.

Common mistakes

Reading "iron studies within reference range" as evidence of adequacy. The lab range is a sedentary-population deficiency threshold. The athlete needs the tighter targets.

Treating ferritin alone as the iron-status marker. Ferritin is the storage marker but it's an acute-phase reactant. Without TSAT and Ret-He alongside, a single normal ferritin can mask functional deficiency.

Skipping hs-CRP on the iron panel. A heavy training block elevates inflammation enough to mask ferritin depletion. Without hs-CRP context, the ferritin reading is uninterpretable.

Supplementing iron daily. The every-other-day schedule absorbs better and produces less GI distress. Hepcidin biology favors pulsing the dose.

Stacking iron with calcium, zinc, or coffee. The supplement reconciliation has to catch this; the athlete will absorb a fraction of what she takes if she's also taking calcium with the same meal.

Re-checking iron status only at intake. Re-check every 6 months for general female-athlete population, every 4 months for copper-IUD users, immediately after any training-load step-up.

Treating the iron deficiency as the diagnosis and stopping there. Persistent or recurrent iron deficiency is often downstream of RED-S, GI pathology, or supplement stack interactions. The iron workup is the entry point; the upstream cause is the actual case.

Where platform tooling helps

The bottleneck in iron-status charting is the multi-marker interpretation and the contraceptive-method cross-reference. Manually correlating ferritin, TSAT, Ret-He, hs-CRP, hemoglobin, contraceptive method, and training-block context across multiple lab draws is the structural work that consumes session time the RD should be spending on the supplementation conversation with the athlete.

The leverage is an iron-status module that ingests lab results (via athlete-uploaded PDF or direct lab integration), classifies the stage from the three-marker primary panel + hs-CRP context, surfaces the contraceptive-method-appropriate target ranges, flags the every-other-day supplementation protocol with vitamin C pairing, and auto-detects absorption-blocker conflicts in the supplement reconciliation.

The RD's job becomes the assessment and the conversation, not the lab interpretation.

The bottom line

Iron-status workup in female athletes needs its own dedicated protocol, not a footnote in the CBC interpretation. The three-marker primary panel — ferritin + TSAT + Ret-He, read against hs-CRP — captures the stage of iron status whether the athlete is in depletion, functional deficiency, or anemia. The contraceptive method changes the monitoring cadence and the supplementation prescription. The every-other-day supplementation protocol with vitamin C pairing absorbs better than daily dosing.

If the current intake captures "iron studies within reference range" and moves on, the chart is missing 80% of the iron-deficient female athletes in the practice. Add the three-marker panel, the staged interpretation, the contraceptive cross-reference, and the optimized supplementation protocol, and the female-athlete workup catches the cases that the lab range hides.

[Calsanova's Dietitian plan](/signup?role=dietitian) ships an iron-status module with three-marker lab ingestion (PDF or direct lab integration), stage classification with hs-CRP context, contraceptive-method-appropriate target ranges, every-other-day supplementation prescriptions with vitamin C pairing, and absorption-blocker conflict detection across the supplement reconciliation. Start your 30-day free trial and turn the iron workup into a clinical record that catches functional deficiency before performance suffers.

Ready to modernize your practice?

Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.

Start your free trial

Get more like this.

Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.

Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson

More from the Classroom

hs-CRP Interpretation in Athletes: Why the Cardiovascular-Risk Reference Range Misreads Training-Driven Elevations, the Ferritin and Iron-Status Cross-Talk the Intake Must Integrate, and the Post-Session Draw-Timing Correction That Separates the Real Cases

A 32-year-old marathon runner arrives at intake with an hs-CRP flagged at 4.8 mg/L on a routine cardiovascular-risk panel, a primary-care recommendation to begin statin therapy for 'elevated cardiovascular inflammation,' and a training week averaging 68 miles across 6 to 7 sessions with a 22-mile long run 36 hours before the draw. The standard hs-CRP interpretation was calibrated in the AHA/CDC cardiovascular-risk-stratification framework — below 1.0 mg/L low risk, 1.0 to 3.0 mg/L average risk, above 3.0 mg/L high risk — using populations dominated by metabolic-syndrome-associated inflammation, and it misclassifies a substantial fraction of the trained-endurance-athlete cases where the elevation is a training-load-driven acute-phase response that resolves off the training window. Reading hs-CRP in isolation misses this case. Here is the structured hs-CRP workup for the sports-nutrition intake: the six-dimension interpretive frame, the acute-vs-chronic draw-timing correction, the ferritin and iron-status cross-talk (hs-CRP is an acute-phase modifier of the iron read), the metabolic-syndrome and body-composition overlay, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the statin-referral read.

August 4, 2026

Creatine Kinase Interpretation in Athletes: Why the Standard Lab Reference Range Misreads Post-Training CK, the Rhabdomyolysis Differential the Sports RD Must Own, and the Weekly-Trending Protocol That Beats a Single Draw

A 24-year-old collegiate rowing coxswain-turned-CrossFit competitor walks into intake with a lab printout that flagged her serum creatine kinase at 4,820 U/L six days after an unaccustomed 40-minute AMRAP that hit her posterior chain hard. Her primary-care nurse practitioner called her to say she was 'in acute kidney failure territory' and told her to go to the emergency department. She went, spent nine hours in observation getting a saline drip and repeat labs, was discharged on 'no exercise for two weeks,' and lost her spot in the qualifier that Saturday. Her second CK draw at the ED — 22 hours after the first — had already dropped to 2,150 U/L. Her creatinine was 0.8 mg/dL throughout. Her urine dipstick was clear for myoglobin. She was, on any reasonable read, a healthy athlete inside a normal post-eccentric CK excursion, misidentified as an incipient rhabdomyolysis on the strength of a single draw compared against a sedentary reference range. The standard laboratory CK reference — usually cited as 30-200 U/L for females and 55-370 U/L for males — was calibrated on adults who did not train. A single post-heavy-training CK draw in an athlete without the ascending-CK, symptom, urine, and renal context tells you almost nothing about muscle injury and much less about kidney risk. Here is the structured CK workup the sports RD should run when a CK value surfaces in the intake or a mid-camp panel: the exercise-induced CK curve, the ULN reset against the athlete population, the rhabdomyolysis-versus-normal-adaptation differential, the weekly-trending protocol that replaces the single-draw misread, the co-management triggers to the sports-medicine physician, and the SOAP pattern that documents the clearance defensibly.

July 23, 2026

Uric Acid Interpretation in Athletes: Why the High-Protein and High-Fructose Sports-Nutrition Diet Confounds the Standard Read, the Renal-vs-Metabolic Differential, and the Purine-Load Audit the Intake Must Run

A 34-year-old ultramarathon runner arrives at intake with a serum uric acid of 8.9 mg/dL flagged as 'hyperuricemia' on a routine metabolic panel, a primary-care referral to a rheumatologist for suspected gout despite no joint symptoms, and a nutrition history dominated by a self-directed high-protein endurance diet, a race-week carbohydrate load leaning on fructose-rich sports drinks, and a training-day sweat rate the workup did not capture. The standard uric acid interpretation was calibrated against a sedentary reference population and misses the athletic case where the elevation runs through a purine-load overlay, a sweat-driven concentration artifact, a fructose-driven hepatic de novo synthesis pathway, and (in a subset of cases) a genuine renal or metabolic disorder the panel is finally surfacing. Reading uric acid in isolation misses this case. Here is the structured uric acid workup for the sports-nutrition intake: the five-dimension interpretive frame, the purine-load audit against the protein and organ-meat pattern, the fructose-load overlay that separates the sports-drink and race-week driver, the sweat-concentration correction the endurance intake must run, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the rheumatology referral.

July 16, 2026